Edition:
United States

Hill-Rom Holdings Inc (HRC.N)

HRC.N on New York Stock Exchange

55.00USD
7 Dec 2016
Change (% chg)

$-0.02 (-0.04%)
Prev Close
$55.02
Open
$54.89
Day's High
$55.31
Day's Low
$54.60
Volume
143,428
Avg. Vol
158,460
52-wk High
$63.10
52-wk Low
$43.01

Summary

Name Age Since Current Position

Rolf Classon

71 2006 Independent Chairman of the Board

Carlos Alonso

56 2015 President, Senior Vice President

John Greisch

60 2010 President, Chief Executive Officer, Director

Steven Strobel

58 2014 Chief Financial Officer, Senior Vice President

Kenneth Meyers

54 2015 Chief Human Resource Officer, Senior Vice President

Susan Lichtenstein

58 2010 Senior Vice President - Corporate Affairs, Chief Legal Officer, Secretary

Andreas Frank

39 2011 Senior Vice President - Corporate Development and Strategy

Alton Shader

42 2015 Senior Vice President and President Front Line Care

Taylor Smith

55 2013 Senior Vice President, President - Surgical and Respiratory Care

Jason Richardson

39 2016 Vice President, Corporate Controller

Richard Keller

54 2016 Vice President - Internal Audit

Michael Macek

43 2014 Treasurer

William Dempsey

65 2014 Director

Enxing Seng

51 2014 Director

James Giertz

58 2009 Independent Director

Charles Golden

69 2002 Independent Director

William Kucheman

66 2013 Independent Director

Ronald Malone

61 2007 Independent Director

Eduardo Menasce

70 2004 Independent Director

Biographies

Name Description

Rolf Classon

Mr. Rolf A. Classon is Independent Chairman of the Board of the company. Mr. Classon became Chairman of the Board of Hill-Rom in 2006. He served as Interim President and Chief Executive Officer of Hill-Rom from May 2005 until March 2006 and as Vice Chairman of the Board from December 2003 until his election as Interim President and Chief Executive Officer. From 2002 to 2004, Mr. Classon served as Chairman of the Executive Committee of Bayer Healthcare AG, the healthcare division of Bayer AG, a global healthcare and chemicals company, and, from 1995 to 2002, Mr. Classon served as President of Bayer Diagnostics. From 1991 to 1995, Mr. Classon was an Executive Vice President in charge of Bayer Diagnostics’ Worldwide Marketing, Sales and Service operations. From 1990 to 1991, Mr. Classon was President and Chief Operating Officer of Pharmacia Biosystems A.B. Prior to 1990, Mr. Classon served as President of Pharmacia Development Company Inc. and Pharmacia A.B.’s Hospital Products Division. Mr. Classon serves as a director of Fresenius Medical Care, Tecan Group and Catalent, Inc., and served as a director of Auxilium Pharmaceuticals, Inc. through 2015.

Carlos Alonso

Mr. Carlos Alonso is a President, Senior Vice President of the company. Mr. Alonso served as the President and CEO of the Esaote Group, a medical imaging leader based in Genova, Italy. Prior to the Esaote Group, Mr. Alonso served as the CEO of Esteve Pharmaceuticals based in Barcelona, Spain, and held various leadership roles of increasing responsibility with Baxter International, Inc. over the course of 15 years, including serving as Global President of the Renal Division.

John Greisch

Mr. John J. Greisch is President, Chief Executive Officer, Director of the company. Mr. Greisch was elected President & Chief Executive Officer of Hill-Rom effective January 8, 2010. Mr. Greisch was most recently President International Operations for Baxter International, Inc., a position he held since 2006. During his seven year tenure with Baxter, he also served as Baxter's Chief Financial Officer and as President of Baxter's BioScience division. Before his time with Baxter, he was President & CEO for FleetPride Corporation in Deerfield, Ill., an independent after-market distribution company serving the transportation industry. Prior to his tenure at FleetPride, he held various positions at The Interlake Corporation in Lisle, Ill., a leading global engineered materials and industrial equipment supplier, including serving as President of the company's Materials Handling Group. Mr. Greisch currently serves on the Board of Directors for Actelion Ltd, and AdvaMed. Additionally, He is on the Board of Directors for Ann & Robert H. Lurie Children's Hospital of Chicago.

Steven Strobel

Mr. Steven J. Strobel has been appointed as Chief Financial Officer, Senior Vice President of the Company. He has been appointed as Senior Vice President of the Company effective November 3, 2014. Before joining Hill-Rom, Strobel was Chief Financial Officer of BlueStar Energy, an independent retail energy services company. Prior to BlueStar, Strobel served as Treasurer and Corporate Controller at Motorola, and in the same positions at Owens Corning. Before that, he worked at Kraft Foods and American Hospital Supply Corporation. Most recently, Strobel was President of McGough Road Advisors, a corporate finance consulting firm. Strobel serves on the Board of Directors of Newell Rubbermaid Inc. where he chairs the Audit Committee.

Kenneth Meyers

Mr. Kenneth F. Meyers is a Chief Human Resource Officer, Senior Vice President of the company. He was Senior Vice President and Chief Human Resources Officer at Hospira, Inc. Previously, he was a partner at Mercer / Oliver Wyman Consulting. Prior to Mercer / Oliver Wyman, he served as Senior Vice President, Human Resources, for Starbucks International.

Susan Lichtenstein

Ms. Susan R. Lichtenstein is Senior Vice President - Corporate Affairs, Chief Legal Officer, Secretary of the company. Previously she was Corporate Vice President and General Counsel at Baxter International, where she was responsible for global legal matters, corporate communications and government affairs. Ms. Lichtenstein has informed the Company that she will be leaving the Company by the end of calendar year 2015.

Andreas Frank

Mr. Andreas G. Frank is Senior Vice President - Corporate Development and Strategy of the company. Mr. Frank was Director Corporate Development at Danaher Corporation. Previously he worked in the Corporate Finance and Strategy practice at the consulting firm McKinsey & Company.

Alton Shader

Mr. Alton Shader is Senior Vice President and President Front Line Care of the company. He had served as Senior Vice President and President, North America since July 2012 and previously as Senior Vice President and President, Post-Acute Care with Hill-Rom since July 2011. Before joining Hill-Rom, Mr. Shader was General Manager of Renal at Baxter International, Inc. Previously, he served as General Manager for Baxter Ireland and held senior marketing positions in Baxter's operations in Zurich and in California.

Taylor Smith

Mr. Taylor Smith is Senior Vice President, President - Surgical and Respiratory Care of Hill-Rom Holdings, Inc. Before joining Hill-Rom. Mr. Smith served as Senior Vice President and General Manager for Cardinal Health’s Orthopedic Products and Services group. Previously he held numerous leadership positions of increasing responsibility at Cardinal Health over the past 13 years.

Jason Richardson

Richard Keller

Mr. Richard G. Keller is Vice President - Internal Audit of the Company. Mr. Keller was Vice President, Chief Accounting Officer, Controller of Hill-Rom Holdings, Inc. He was elected Vice President, Controller and Chief Accounting Officer of the Company effective August 2005. He had served as Executive Director - Controller of Hill-Rom since March 2004.

Michael Macek

Mr. Michael Macek is Treasurer of the company. He is no longer serve as Interim Chief Financial Officer and Principal Financial Officer of the Company effective December 1, 2014. Michael Macek was elected Treasurer for Hill-Rom effective March, 2011 and designated Interim Chief Financial Officer in July, 2013. Mr. Macek held the position of Executive Director, Treasury for Hill-Rom since 2008. Prior to joining Hill-Rom in 2005, he held financial positions of increasing responsibility with Ernst & Young and Guidant Corporation. Mr. Macek holds an undergraduate degree from Indiana University and a Master of Business Administration (MBA) degree from the Kelley School of Business at Indiana University.

William Dempsey

Mr. William G. Dempsey is the director of the company. Mr. Dempsey previously held various executive positions with Abbott Laboratories from 1982 until 2007, including, Executive Vice President of Global Pharmaceuticals from 2006, Senior Vice President of Pharmaceutical Operations from 2003 and Senior Vice President of International Operations from 1999. He currently serves as a director of Landauer Inc., and was on the board of Nordion, Inc. through 2014 and Hospira, Inc., through 2015. He has previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies. He is a member of the Salvation Army Advisory Board in Chicago and the Board of Trustees for the Guadalupe Center in Immokalee, Florida.

Enxing Seng

Ms. Enxing Seng is a director of the company, She is the former President, Peripheral Vascular of Covidien from 2012 to 2014, and Executive in Residence for Covidien in 2014. Prior to that, she was President, Vascular Therapies, of Covidien from 2010 to 2012. Ms. Enxing Seng joined Covidien in 2010 through the $2.6B acquisition of ev3 Incorporated, where she was a founding member and executive officer responsible for leading their Peripheral Vascular division from 2001 to 2010. Prior to that, she held positions of increasing responsibility with SCIMED, Boston Scientific, American Hospital Supply and Baxter. Ms. Enxing Seng currently serves on the boards of Sonova Holding AG, Solace Therapeutics, and Spirox, Inc., and was formerly on the boards of FIRE 1 Medical Incubator and CV Ingenuity.

James Giertz

Mr. James R. Giertz is Independent Director of the company. He has been Executive Vice President and Chief Financial Officer of H.B. Fuller Company, St. Paul, Minnesota, since March 2008. Prior to joining H.B. Fuller, he served as Senior Managing Director, Chief Financial Officer and, for several months in 2007 a director, of Residential Capital, LLC, one of the largest originators, servicers and securitizers of home loans in the United States. Prior to that, he was Senior Vice President of the Industrial Products division, and Chief Financial Officer of Donaldson Company, Inc., a worldwide provider of filtration systems and replacement parts. In addition, Mr. Giertz served as assistant treasurer of the parent company at General Motors, and also held several international treasury positions in Canada and Europe. Mr. Giertz also serves on the Board of the Junior Achievement of the Upper Midwest and the Board of Regents of Concordia University of St. Paul.

Charles Golden

Mr. Charles E. Golden is Independent Director of the company. He served as Executive Vice President and Chief Financial Officer and a director of Eli Lilly and Company, an international developer, manufacturer and seller of pharmaceutical products, from 1996 until his retirement in 2006. Prior to joining Eli Lilly, he had been associated with General Motors Corporation since 1970, where he held a number of positions, including Corporate Vice President, Chairman and Managing Director of the Vauxhall Motors subsidiary and Corporate Treasurer. He is currently on the board of Eaton Corporation PLC, and was formerly on the boards of Unilever NV/PLC through 2014. He also serves as a director of the Lilly Endowment and Indiana University Health.

William Kucheman

Mr. William H. Kucheman is Independent Director of the company. He previously served as interim Chief Executive Officer for Boston Scientific Corp. Before being named interim CEO in October 2011, he was Executive Vice President and President of the Cardiology, Rhythm and Vascular (CRV) Group of Boston Scientific. He joined the Company in 1995 as a result of Boston Scientific’s acquisition of SCIMED Life Systems, Inc., becoming Senior Vice President of Marketing. In this role, Mr. Kucheman was responsible for global marketing. He has served on several industry boards, including the board of directors of the Global Health Exchange and on the boards of several non-public companies.

Ronald Malone

Mr. Ronald A. Malone is Independent Director of the company. He served as Chairman of the Board of Gentiva Health Services from 2002 to 2011, as Chief Executive Officer from 2002 through 2008, and as a director through 2012. He joined Gentiva in 2000 as Executive Vice President and President of Gentiva’s Home Health Division. Prior to joining Gentiva, he served in various positions with Olsten Corporation including Executive Vice President of Olsten Corporation and President, Olsten Staffing Services, United States and Canada. He is a director of Capital Senior Living, Inc., a former director of the National Association for Home Care & Hospice and a former director and chairman of the Alliance for Home Health Quality and Innovation.

Eduardo Menasce

Mr. Eduardo R. Menasce is Independent Director of the company. He is the retired President of the Enterprise Solutions Group for Verizon Communications, Inc. Prior to Verizon, he was the President and Chief Executive Officer of CTI MOVIL S.A. (Argentina), a business unit of GTE Corporation, from 1996 to 2000, and also held senior positions at CANTV in Venezuela, Wagner Lockheed and Alcatel in Brazil, and GTE Lighting in France. Mr. Menascé currently serves on the Boards of Directors of Pitney Bowes Inc., John Wiley & Sons, Inc. and Hillenbrand, Inc., and formerly served on the board of KeyCorp. Mr. Menascé is a Co-Chairman of The Taylor Companies, a privately held global investment bank which specializes exclusively in mergers, acquisitions and divestitures. He is also a member of the Board of Directors of Daybreak, a non-profit charitable organization focused on funding research for rare genetic diseases.